BioCardia Analyst Price Targets - Benzinga

BioCardia Inc

BCDANASDAQ

Trade with Public

Trade with Public

$1.06

-0.03-2.75%

마지막 업데이트: Oct 9, 4:24 AM

$1.04

-0.05-4.59%

개요 뉴스 실적 전망 이벤트목표가재무 심리 지분 현황 비교 주식 보고서

BioCardia Analyst Price Targets - Benzinga

BioCardia Analyst Price Targets

Wall Street analyst price targets and consensus rating for BioCardia (BCDA).

Price Target Range — 7 Quarters

Analyst Consensus — 1 Analysts

1Buy

Consensus RatingBuy# Analysts1Avg. Consensus PT$25Upside to Avg. PT+2303.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 24, 2026	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$25
Jun 9, 2026	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$25
Sep 22, 2025	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$25
Dec 18, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$25
Nov 14, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$25
Oct 28, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$25
Aug 21, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$25
Aug 16, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$4→$25
Jul 26, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$4
May 29, 2024	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$4
Nov 14, 2023	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$4
Oct 11, 2023	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$4

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioCardia (NASDAQ:BCDA) with a Buy and maintains $25 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioCardia (NASDAQ:BCDA) with a Buy and maintains $25 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioCardia (NASDAQ:BCDA) with a Buy and maintains $25 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioCardia (NASDAQ:BCDA) with a Buy and maintains $25 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioCardia (NASDAQ:BCDA) with a Buy and maintains $25 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioCardia (NASDAQ:BCDA) with a Buy and maintains $25 price target.

Benzinga Newsdesk